[
  {
    "ts": null,
    "headline": "Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions",
    "summary": "BOSTON, June 20, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data from the Phase 1/2 portion of the Phase 1/2/3 FORWARD-101 clinical trial of zimislecel (VX-880), an investigational stem cell-derived, fully differentiated islet cell therapy, in people with type 1 diabetes (T1D) with impaired hypoglycemic awareness and severe hypoglycemic events (SHEs). The data were featured in an oral presentation at the American",
    "url": "https://finnhub.io/api/news?id=ad5bf501032db6e72c758c717a7ea0ad47a57714e7a68eef18efaa94afbf1445",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750461300,
      "headline": "Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions",
      "id": 135456584,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "BOSTON, June 20, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data from the Phase 1/2 portion of the Phase 1/2/3 FORWARD-101 clinical trial of zimislecel (VX-880), an investigational stem cell-derived, fully differentiated islet cell therapy, in people with type 1 diabetes (T1D) with impaired hypoglycemic awareness and severe hypoglycemic events (SHEs). The data were featured in an oral presentation at the American",
      "url": "https://finnhub.io/api/news?id=ad5bf501032db6e72c758c717a7ea0ad47a57714e7a68eef18efaa94afbf1445"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market",
    "summary": "In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $440.87, denoting a -1.68% move from the preceding trading day.",
    "url": "https://finnhub.io/api/news?id=6765d37b5e91c175dbda3b75e2efac07fb9cdfde2c34ce40fce9bd5d9360a376",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750456805,
      "headline": "Here's Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market",
      "id": 135456585,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $440.87, denoting a -1.68% move from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=6765d37b5e91c175dbda3b75e2efac07fb9cdfde2c34ce40fce9bd5d9360a376"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Vertex Pharmaceuticals Incorporated Presents at American Diabetes Association 85th Scientific Sessions, Jun-20-2025 07",
    "summary": "Presenter SpeechSusie Lisa Thanks for your patience. Good evening, everyone. My name is Susie Lisa, and I'm the Senior Vice President of Investor Relations for Vertex Pharmaceuticals. Thank you so...",
    "url": "https://finnhub.io/api/news?id=c1e3d954b178d6f187c1e72a49905836e01eb8b5cba94836e5c535756ebd2a5d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750456522,
      "headline": "Transcript : Vertex Pharmaceuticals Incorporated Presents at American Diabetes Association 85th Scientific Sessions, Jun-20-2025 07",
      "id": 135446215,
      "image": "",
      "related": "VRTX",
      "source": "Finnhub",
      "summary": "Presenter SpeechSusie Lisa Thanks for your patience. Good evening, everyone. My name is Susie Lisa, and I'm the Senior Vice President of Investor Relations for Vertex Pharmaceuticals. Thank you so...",
      "url": "https://finnhub.io/api/news?id=c1e3d954b178d6f187c1e72a49905836e01eb8b5cba94836e5c535756ebd2a5d"
    }
  },
  {
    "ts": null,
    "headline": "Vertex (VRTX) Stock PT Lowered to $420 on slower Alyftrek Uptake",
    "summary": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the 10 biotech stocks screaming a buy. On June 17, RBC Capital reiterated a Sector Perform rating on the stock but cut the price target to $420 from $423. The adjustment is in response to the company confirming gradual patient conversion from Trikafta to the company’s next-generation cystic […]",
    "url": "https://finnhub.io/api/news?id=35677873042d78a1674f4ee5e3188ee885f776d7f04bee164144d4a65eaba291",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750450033,
      "headline": "Vertex (VRTX) Stock PT Lowered to $420 on slower Alyftrek Uptake",
      "id": 135456586,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the 10 biotech stocks screaming a buy. On June 17, RBC Capital reiterated a Sector Perform rating on the stock but cut the price target to $420 from $423. The adjustment is in response to the company confirming gradual patient conversion from Trikafta to the company’s next-generation cystic […]",
      "url": "https://finnhub.io/api/news?id=35677873042d78a1674f4ee5e3188ee885f776d7f04bee164144d4a65eaba291"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
    "summary": "Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=dbe28c3ccdf639e0d39e2ae72bbf7c9c3a99f896117ef20b9bc55f2d371933a7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750437420,
      "headline": "Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
      "id": 135479166,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=dbe28c3ccdf639e0d39e2ae72bbf7c9c3a99f896117ef20b9bc55f2d371933a7"
    }
  }
]